These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4364644)

  • 1. Lead aggravates viral disease and represses the antiviral activity of interferon inducers.
    Gainer JH
    Environ Health Perspect; 1974 May; 7():113-9. PubMed ID: 4364644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of arsenicals on viral infections in mice.
    Gainer JH; Pry TW
    Am J Vet Res; 1972 Nov; 33(11):2299-307. PubMed ID: 4343075
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivities of neurotropic arboviruses to human interferon.
    Luby JP
    J Infect Dis; 1975 Oct; 132(4):361-7. PubMed ID: 171314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.
    Sonnenfeld G; Tovey M; Schellekens H; Kinney KS; Belay T; Morton DS; Austin CE; Reitman M; Fong TA; Vaughan HS
    J Interferon Cytokine Res; 2001 Jul; 21(7):539-45. PubMed ID: 11506749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon inducers: enhancement of viral oncogenesis in mice and rats.
    Gazdar AF; Steinberg AD; Spahn GF; Baron S
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1132-7. PubMed ID: 5023305
    [No Abstract]   [Full Text] [Related]  

  • 7. Brefeldin A inhibits the antiviral action of interferon against encephalomyocarditis virus.
    Sidhu GS; Singh AK; Raghunath PN; Sivaram S; Maheshwari RK
    Virus Res; 1996 Feb; 40(2):123-33. PubMed ID: 8725108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of thymosin on interferon production and antiviral resistance in mice].
    Nosik NN; Parshina OV; Khromov IS; Ershov FI
    Vopr Virusol; 1985; 30(1):64-7. PubMed ID: 2581368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiviral activity of murine interferons produced by bacterial and animal cell translation of messenger RNA].
    Mamontova TV; Mentkevich LM; Orlova TG
    Vopr Virusol; 1980; (1):63-7. PubMed ID: 6158177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells.
    Czarniecki CW; Allen PT
    Antiviral Res; 1984 Dec; 4(6):351-5. PubMed ID: 6099710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by streptovaricins of Rauscher leukemia virus splenomegaly.
    Borden EC; Carter WA; Sensenbrenner LL; Owens AH; Lichtenstein J; Gray GD; Neil GL; Nichol FR; Li LH
    Int J Cancer; 1974 Dec; 14(6):817-25. PubMed ID: 4156850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of virus multiplication by selected isothiocyanates.
    Rada B; Hanusovská T; Drobnica L; Nĕmec P
    Acta Virol; 1971 Jul; 15(4):329-32. PubMed ID: 4398087
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus.
    Kaptur PE; Thomas DC; Giron DJ
    J Interferon Res; 1989 Dec; 9(6):671-8. PubMed ID: 2481700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mengovirus infection in mice with statolon.
    Pindak FF; Schmidt JP
    Appl Microbiol; 1967 Sep; 15(5):1240-3. PubMed ID: 4294823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of high doses of poly(I).poly(C) induced mouse L cell interferon on Rauscher leukemia virus induced erythroleukemia in BALB/c mice.
    Hekman RA; Prins ME; Bosveld IJ; Trapman J
    Int J Cancer; 1981; 27(4):493-500. PubMed ID: 6168593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and host resistance to Rauscher virus-induced leukemia.
    Glasgow LA; Friedman SB
    J Virol; 1969 Feb; 3(2):99-105. PubMed ID: 5774143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral factors required for interferon induction by Newcastle disease virus in mouse macrophages and chicken embryo cells.
    Azuma M
    J Gen Virol; 1976 Jan; 30(1):51-62. PubMed ID: 942745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid.
    Billiau A; Desmyter J; De Somer P
    J Virol; 1970 Mar; 5(3):321-8. PubMed ID: 4314554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
    Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
    J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tunicamycin treatment inhibits the antiviral activity of interferon in mice.
    Maheshwari RK; Husain MM; Attallah AM; Friedman RM
    Infect Immun; 1983 Jul; 41(1):61-6. PubMed ID: 6190759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.